Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin added to growth hormone in short children born small for gestational age
ISRCTN19548431Phase 2Completed
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Apr 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Short stature in children born small for gestational age comparing Metformin + growth hormone with Placebo + growth hormone (2 arms). Primary endpoints: Insulin sensitivity at 18 months, Fasting insulin at 18 months and 1 more. Started Apr 2010; status: completed.
02
Drugs
metforminsomatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on ISRCTN19548431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN19548431.